Germany (Co-Chair)
ESMO ADVANCED COURSES
Live interactive educational courses comprising of 1.5 to 2 days of plenary lectures and case-based sessions for experienced oncologists and specialists navigating complex clinical challenges
ABOUT ESMO ADVANCED COURSES 2026
ESMO Advanced Courses include in-person plenary lectures and case-based sessions with a multidisciplinary faculty of 8-10 international experts. The courses aim to address specific advanced challenges in patient management in different tumour settings and include in-depth, select lectures, workshops and interactive discussion seminars.
ESMO Advanced Courses cover a wide range of therapy areas
BREAST CANCER
GASTROINTESTINAL CANCERS
GENITOURINARY CANCER
GYNAECOLOGICAL CANCERS
THORACIC MALIGNANCIES
SUPPORTIVE CARE
2026 ADVANCED COURSES CALENDAR
ESMO Advanced Course on Precision Medicine for Patients with HR+ HER2- Advanced Breast Cancer: Testing, Selecting, Treating 2026
4-5 MAR 2026 – ZURICH, SWITZERLAND
France (Co-Chair)
ESMO Advanced Course on Management of Patients with Localised Bladder Cancer: State-of-the-Art Therapeutic Strategies and Ongoing Research 2026
6-7 MAR 2026 – ZURICH, SWITZERLAND
Germany (Co-Chair)
UK (Co-Chair)
ESMO Advanced Course on Early Stage Non-Small-Cell Lung Cancer 2026
23-24 APRIL 2026 – ATHENS, GREECE
Greece (Co-Chair)
Greece (Co-Chair)
Greece (Co-Chair)
ESMO-EANM Advanced Course on Diagnostic and Therapeutic Applications of Nuclear Medicine in Oncology 2026
12-13 MAY 2026 – ESSEN, GERMANY
Italy (Co-Chair)
Germany (Co-Chair)
ESMO Advanced Course on Brain Metastases in Lung and Breast Cancer 2026
11-12 NOV 2026 – BARCELONA, SPAIN
Sweden (Co-Chair)
Netherlands (Co-Chair)
Netherlands (Co-Chair)
ESMO Advanced Course on Cholangiocarcinoma 2026
13-14 NOV 2026 – BARCELONA, SPAIN
France (Co-Chair)
Spain (Co-Chair)
ESMO ADVANCED COURSE METRICS 2025
594
57
58.7%
121
66
BENEFITS FOR OUR PARTNERS
FUNDING OPTIONS
Support type |
Funding amount per sponsor (EUR) |
|---|---|
| 100% funding (single sponsor) | € 162,000 |
| 50% funding (2 sponsors) | € 81,000 |


